ReviewThe European journal of health economics : HEPAC : health economics in prevention and care2014

Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?

María-Isabel Farfan-Portet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.